Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Rater-Blinded Study to Explore the Effect of Mefloquine in Subjects With Progressive Multifocal Leukoencephalopathy (PML)

NCT00746941 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT00746941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00746941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Rater-Blinded Study to Explore the Effect of Mefloquine in Subjects With Progressive Multifocal Leukoencephalopathy (PML)
Lead sponsor
Biogen
Phase
Phase 1/2
Overall status
Terminated
Start date
January 31, 2009
Completion date
November 30, 2010
Enrollment
37 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

progressive multifocal leukoencephalopathy